We Care for the Liver,
We Care for
Cell Signaling Technology
for Liver Repair
& Organ Regeneration
Cellaïon is a Belgian biotechnology company developing life-saving advanced therapies that aim to repair tissues and regenerate organs, particularly the liver. Cellaïon targets life-threatening diseases.
We, at Cellaïon, are developing HepaStem® with an aim to restore the human body’s regenerative process and to support the survival of a failing native liver
What we do
We aim to repair tissues and regenerate organs using cell signaling technology
Our prime target is the liver space. The liver is a critical organ of the body that is responsible for an array of functions. Any downfall of its functioning leads to failure of other vital organs and ultimately death.
With HepaStem®, Cellaïon aims to stop the progression of chronic liver disease, control inflammation, stop fibrous tissue accumulation in the liver and eventually allow recovery and regeneration of the liver.
Do you want to know more about us or our last research?
Interested to learn more about Cellaïon?
Do you want to know more about us or our clinical trials? Interested to learn more about Cellaïon, HepaStem® and ongoing trials?
Clinical Trial / Publication
A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation.
Published in April 2021 in JHEP Liver
Explore our selection of research articles and news